Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
about
AST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits antitumor activity both in vitro and in vivoUnnatural polyketide analogues selectively target the HER signaling pathway in human breast cancer cells.The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo.Synthesis and cytotoxic evaluation of some new[1,3]dioxolo[4,5-g]chromen-8-one derivatives.Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin.Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors.Development and experimental test of support vector machines virtual screening method for searching Src inhibitors from large compound libraries.YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.Natural products as kinase inhibitors.cis-Diastereoselective synthesis of chroman-fused tetralins as B-ring-modified analogues of brazilinLenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.Homoisoflavonoids and Chalcones Isolated from Haematoxylum campechianum L., with Spasmolytic Activity.Enantioselective total synthesis of (+)-brazilin, (-)-brazilein and (+)-brazilide A.Chemical constituents from the heartwood of Haematoxylon campechianum as protein tyrosine kinase inhibitors.Investigating flavonoids as molecular templates for the design of small-molecule inhibitors of cell signaling.
P2860
Q28479059-B64374CB-304E-488D-984E-4EADE0BD49E2Q30500245-BABF0C10-9A87-41B9-80E4-8384624E3E10Q33385649-462FCA78-D366-473A-A2D2-6E397C928363Q33606317-8F084FAF-4E84-42E7-B3BA-833A8C896C07Q33869726-494AEDC7-04E8-459F-B202-1E5DC4978C00Q33923364-03494D70-6BD2-49A5-BD3C-350D411D9F55Q34485998-5EF87A53-7BDA-4B42-94AE-81A99844D5EEQ37122693-89054485-6D64-4E0E-A537-1441AA01D7CEQ37974484-858FDC22-B1BD-47AC-BBA1-01642B5735A0Q38763534-A0FE1BDA-DBFE-4737-9CA9-7DDDDB0A8DEEQ39207485-ABE4792C-E97A-4F72-9002-2E9680E3372EQ47727550-49DB1217-9156-495D-98C4-E72AB6062F2CQ51813068-904418B7-F136-4984-AC5D-989A9689E30DQ54352724-C67451D6-4C35-48A8-B2E9-BC6369CAEC10Q54453411-D436427C-8CA0-47F5-A25A-A16A8ED15C1F
P2860
Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Naturally occurring homoisofla ...... sed high-throughput screening.
@ast
Naturally occurring homoisofla ...... sed high-throughput screening.
@en
type
label
Naturally occurring homoisofla ...... sed high-throughput screening.
@ast
Naturally occurring homoisofla ...... sed high-throughput screening.
@en
prefLabel
Naturally occurring homoisofla ...... sed high-throughput screening.
@ast
Naturally occurring homoisofla ...... sed high-throughput screening.
@en
P2093
P356
P1476
Naturally occurring homoisofla ...... sed high-throughput screening.
@en
P2093
Chang-Qiang Ke
Chun-Ping Tang
Hong-Lin Li
Hualiang Jiang
Li-Gen Lin
Li-Ping Lin
Lin-Jiang Tong
Mei-Yu Geng
P304
P356
10.1021/JM701501X
P407
P577
2008-07-09T00:00:00Z